New European scheme sets quality standards for breast cancer care

The first official version of the European quality assurance scheme for breast cancer services is now available on the European Commission web hub.

Boston Scientific to buy back pain treatment company Relievant for $850M

Dive Brief: Boston Scientific reached an agreement to acquire neuromodulation company Relievant Medsystems for $850 million upfront, the companies announced on Tuesday. Sunnyvale, California-based Relievant

September 19, 2023

Scientists successfully unfroze rat organs and transplanted them — a ‘historic’ step that could someday transform transplant medicine

The rat kidney was peculiarly beautiful — an edgeless viscera about the size of a quarter, gemstone-like and gleaming as if encased in pure glass.

June 21, 2023

CMS change could slow the crucial growth of ‘food as medicine’

Sometimes, an apple a day really is just what the doctor ordered. And for the past several years, organizations like About Fresh, the Boston-based nonprofit

June 27, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.